Want to join the conversation?
$GS 2Q15 PR: Net revenues were $9,069MM, down 0.61% from $9,125MM in 2Q14. Net earnings applicable to common shareholders were $916MM, down 53.1% from $1,953MM in 2Q14. 1H15: Net revenues were $19,686MM, up 6.68% from $18,453MM in 1H14. Net earnings applicable to common shareholders were $3,664MM, down 6% from $3,902MM in 1H14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?